November 23, 2021
According to the report titled ‘GLOBAL Infertility Testing And Treatment Market 2021-2028’ available with MarketStudyReport, global infertility testing & treatment market is expected to grow at 10.15% CAGR during the forecast period 2021-2028.
Rise in stress levels and consequent prevalence of lifestyle disorders, enhanced government support, and present trend of late marriages and pregnancies are propelling the growth of global infertility testing and treatment market.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3977452/
Additionally, breakthroughs in time-lapse technology, and medical advancements in embryo biopsy & genetic screening are projected to elevate the market expansion in the forthcoming years.
However, high cost of treatments and risks associated with them, as well as social stigma surrounding infertility are expected to impede the industry growth during the forecast period.
Based on gender, worldwide infertility testing and treatment market is divided into males, and females. The male segment is further categorized into male infertility testing (sperm penetration assay, computer-assisted semen analysis, microscopic examination, DNA fragmentation, oxidative stress analysis, sperm accumulation, others), and male infertility treatment (medication, assisted reproductive technology & varicocele surgery). The female segment is classified into female infertility testing (hormonal level testing, laparoscopy, ovulation testing, ovarian reserve testing, hysterosalpingography, transvaginal ultrasound, others), and female infertility treatment (surrogacy, IVF with ICSI, IVF without ICSI, IUI, others).
In terms of end-user, the market is bifurcated into cryobanks, fertility & surgical centers, and hospitals & research laboratories.
From the regional standpoint, Asia Pacific market is anticipated to account for a sizable revenue share over the forecast period, owing to an uptick in the adoption of fertility procedures, a boost in fertility tourism, and low treatment costs in countries such as India, South Korea, Thailand, and Singapore. Furthermore, improved awareness regarding healthcare, and availability of skilled professionals will also acts as growth stimulants for the regional market.
The competitive landscape of worldwide infertility testing & treatment industry is defined by companies like Bangkok IVF Center, Cook Group Incorporated, Halotech DNA, EMD Group, Fujifilm Irvine Scientific, Labotect GmbH, Ferring Pharmaceuticals, Adorefem, Olympus Corporation, Vitrolife AB, Create Fertility Centre, Progyny Inc., Endo International plc, Genea Ltd., and CooperSurgical Inc. among others.